LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Natus Medical Incorporated (“Natus” or the “Company”) (Nasdaq: BABY) concerning possible violations of federal securities laws between October 16, 2015 and April 3, 2016 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the March 31, 2017 lead plaintiff motion deadline.
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
The complaint alleges that during the Class Period, Natus made materially false and/or misleading statements, and/or failed to disclose that: the Venezuelan government failed to make tens of millions of dollars in prepayments to Natus, which were required to have been paid beginning in October 2015; that Natus had no means to effectively enforce its rights under its supply contract, as Venezuela was the exclusive forum for dispute resolution; that the Company’s receipt of revenues pursuant to the supply contract was contingent on the outcome of Venezuelan elections; and that as a result of the above, Natus was not going to achieve the increased guidance provided by the Company which lacked a reasonable basis. When this news was announced to the public, shares of Natus declined in value, causing investors harm.
Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.